Valeritas plans to sell common stock in initial public offering

Piper Jaffray, Leerink Partners and Oppenheimer are underwriters

By Angela McDaniels

Tacoma, Wash., Feb. 12 – Valeritas, Inc. announced plans for an initial public offering of common stock with a greenshoe.

Piper Jaffray & Co., Leerink Partners LLC and Oppenheimer & Co. Inc. are the underwriters, according to an S-1 filing with the Securities and Exchange Commission.

The company has applied to have its shares listed on the Nasdaq Global Market under the ticker symbol “VLRX.”

The company will use the proceeds to expand and support its sales and marketing infrastructure and activities; to fund research, development and engineering activities and manufacturing capabilities and for working capital and other general corporate purposes.

Bridgewater, N.J.-based Valeritas is a medical device company focused on Type 2 diabetes.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.